Research and Markets (http://www.researchandmarkets.com/research/d6849d/vertigo_therapy_ar)
has announced the addition of the "Vertigo
Therapy Area Pipeline Report" report to their offering.
Life Science Analytics, Vertigo
Therapy Area Pipeline Report contains detailed information on the
vertigo drug pipeline. This report provides insight into the pipeline
status of vertigo drugs by company and by stage as well as a summary of
the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the
user with real detail on drug pipelines, by company and by stage, for
each specific therapy area. The latest news, by company, also ensures
that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects,
each report also contains extensive information in tabular format on a
company's full product pipeline and products by phase of development
with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed
product descriptions, information on partnering activity plus clinical
trial intelligence. Each Therapy Area Pipeline Report also provides
detail on the top 20 companies with products in the early stage of
development and the top 20 companies with products in the late stage of
development. Finally, each report also provides a comparison with other
major indications in the disease hub based on Marketed Products vs.
Pipeline Products.
Key benefits